Utility of COVID‐19 antigen testing in the emergency department

Utility of COVID‐19 antigen testing in the emergency department

Abstract Background The BinaxNOW coronavirus disease 2019 (COVID‐19) Ag Card test (Abbott Diagnostics Scarborough, Inc.) is a lateral flow immunochromatographic point‐of‐care test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) nucleocapsid protein antig...

Full description

Bibliographic Details
Main Authors: W. Frank Peacock, Karina M. Soto‐Ruiz, Stacey L. House, Chad M. Cannon, Gary Headden, Brian Tiffany, Sergey Motov, Kian Merchant‐Borna, Anna Marie Chang, Claire Pearson, Brian W. Patterson, Alan E. Jones, Joseph Miller, Joseph Varon, Aveh Bastani, Carol Clark, Zubaid Rafique, Bory Kea, John Eppensteiner, James M. Williams, Simon A. Mahler, Brian E. Driver, Phyllis Hendry, Eugenia Quackenbush, David Robinson, Jon W. Schrock, James P. D'Etienne, Christopher J. Hogan, Anwar Osborne, Ralph Riviello, Stephen Young
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American College of Emergency Physicians Open
Subjects:
antigen testing
Covid‐19
diagnostic devices
emergency department
nasal swab
point of care
Online Access:https://doi.org/10.1002/emp2.12605

Internet

https://doi.org/10.1002/emp2.12605

Similar Items